The
Clinical Pharmacogenetics Implementation Consortium (CPIC) was established in order to provide drug-dosing guidelines based on an individual’s genotype, if this genetic information is already available. These guidelines are published in
Clinical Pharmacology and Therapeutics and summaries of the
guidelines can be viewed in the PharmGKB on drug or gene pages.
Find out more about
CPIC, and the
CPIC gene-drug pairs.